Alerts will be sent to your verified email
Verify Email
VENUSREM
|
Venus Remedies
|
Kilitch Drugs(India)
|
Fredun Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.87 % | 4.81 % | 8.53 % |
|
5yr Avg Net Profit Margin
|
6.91 % | 6.07 % | 2.89 % |
|
Price to Book
|
1.1 | 3.07 | 3.93 |
|
P/E
|
11.46 | 22.18 | 23.7 |
|
5yr Avg Cash Conversion Cycle
|
46.96 Days | -7.56 Days | 137.13 Days |
|
5yr Average Interest Coverage Ratio
|
396.11 | 5.07 | 2.31 |
|
5yr Avg ROCE
|
8.42 % | 8.16 % | 16.75 % |
|
5yr Avg Operating Profit Margin
|
10.14 % | 9.07 % | 8.32 % |
|
5 yr average Debt to Equity
|
0.08 | 0.14 | 0.86 |
|
5yr CAGR Net Profit
|
-6.01 % | 77.02 % | 52.4 % |
|
5yr Average Return on Assets
|
6.69 % | 3.38 % | 3.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.76 % | 69.23 % | 48.93 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.98 % | -2.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venus Remedies
|
Kilitch Drugs(India)
|
Fredun Pharma
|
|---|